title: [Bronchial hyperresponsiveness and its importance for the clinician].
abstract: Asthma is a chronic inflammatory airway disease, characterised by bronchial hyperresponsiveness causing bronchoconstriction, and thereby provoking typical symptoms (dyspnoea, cough, wheezing). Bronchial hyperres- ponsiveness indicates a temporary airflow limitation when exposed to a bronchoconstricting stimulus. Its measurement by challenge tests can be a valuable tool for confirming or excluding asthma, as well as for evaluating the efficacy of treatment. However, the origin of bronchial hyperresponsiveness is multifactorial and the different challenge tests are not equivalent. Direct challenge tests, like methacholine, mainly reflect chronic airway remo- delling, whereas indirect tests, like mannitol, better reflect bronchial inflammation.
authors.affiliation: CHUV, Lausanne.
authors.forename: A
authors.initials: A
authors.lastname: Mihalache
authors.forename: J-W
authors.initials: JW
authors.lastname: Fitting
mesh_terms: D001249:Asthma / Q000209:etiology / Q000628:therapy; D016535:Bronchial Hyperreactivity / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D001985:Bronchial Provocation Tests / Q000379:methods; D005080:Exercise Test; D006801:Humans; D010818:Practice Patterns, Physicians'